J Martin Carroll - Net Worth and Insider Trading

J Martin Carroll Net Worth

The estimated net worth of J Martin Carroll is at least $137,636 dollars as of 2024-05-31. J Martin Carroll is the Director of Esperion Therapeutics Inc and owns about 36,500 shares of Esperion Therapeutics Inc (ESPR) stock worth over $83,585. J Martin Carroll is the Director of Rocket Pharmaceuticals Inc and owns about 2,500 shares of Rocket Pharmaceuticals Inc (RCKT) stock worth over $53,625. J Martin Carroll is also the Director of TherapeuticsMD Inc and owns about 200 shares of TherapeuticsMD Inc (TXMD) stock worth over $426. Besides these, J Martin Carroll also holds Mallinckrodt PLC (MNKKQ) . Details can be seen in J Martin Carroll's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that J Martin Carroll has not made any transactions after 2023-05-11 and currently still holds the listed stock(s).

Transaction Summary of J Martin Carroll

To

J Martin Carroll Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, J Martin Carroll owns 7 companies in total, including Catalent Inc (CTLT) , TherapeuticsMD Inc (TXMD) , and Mallinckrodt PLC (MNKKQ) among others .

Click here to see the complete history of J Martin Carroll’s form 4 insider trades.

Insider Ownership Summary of J Martin Carroll

Ticker Comapny Transaction Date Type of Owner
CTLT Catalent Inc 2016-08-24 director
TXMD TherapeuticsMD Inc 2015-05-08 director
MNKKQ Mallinckrodt PLC 2022-06-16 director
LIMIT LIMIT 2016-05-13 director
LIMIT LIMIT 2013-08-14 director
LIMIT LIMIT 2023-05-11 director
LIMIT LIMIT 2022-06-16 director

J Martin Carroll Latest Holdings Summary

J Martin Carroll currently owns a total of 4 stocks. Among these stocks, J Martin Carroll owns 36,500 shares of Esperion Therapeutics Inc (ESPR) as of May 11, 2023, with a value of $83,585 and a weighting of 60.73%. J Martin Carroll owns 2,500 shares of Rocket Pharmaceuticals Inc (RCKT) as of May 13, 2016, with a value of $53,625 and a weighting of 38.96%. J Martin Carroll also owns 200 shares of TherapeuticsMD Inc (TXMD) as of May 8, 2015, with a value of $426 and a weighting of 0.31%. The other 1 stocks Mallinckrodt PLC (MNKKQ) have a combined weighting of 0% among all his current holdings.

Latest Holdings of J Martin Carroll

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ESPR Esperion Therapeutics Inc 2023-05-11 36,500 2.29 83,585
RCKT Rocket Pharmaceuticals Inc 2016-05-13 2,500 21.45 53,625
TXMD TherapeuticsMD Inc 2015-05-08 200 2.13 426
MNKKQ Mallinckrodt PLC 2021-03-12 0 0.02 0

Holding Weightings of J Martin Carroll


J Martin Carroll Form 4 Trading Tracker

According to the SEC Form 4 filings, J Martin Carroll has made a total of 1 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 31,500 shares on May 11, 2023, which cost J Martin Carroll around $48,825.

According to the SEC Form 4 filings, J Martin Carroll has made a total of 0 transactions in Rocket Pharmaceuticals Inc (RCKT) over the past 5 years. The most-recent trade in Rocket Pharmaceuticals Inc is the acquisition of 2,500 shares on May 13, 2016, which cost J Martin Carroll around $90,300.

According to the SEC Form 4 filings, J Martin Carroll has made a total of 0 transactions in TherapeuticsMD Inc (TXMD) over the past 5 years. The most-recent trade in TherapeuticsMD Inc is the acquisition of 200 shares on May 8, 2015, which cost J Martin Carroll around $61,100.

More details on J Martin Carroll's insider transactions can be found in the Insider Trading History of J Martin Carroll table.

Insider Trading History of J Martin Carroll

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

J Martin Carroll Trading Performance

GuruFocus tracks the stock performance after each of J Martin Carroll's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by J Martin Carroll is -5.95%. GuruFocus also compares J Martin Carroll's trading performance to market benchmark return within the same time period. The performance of stocks bought by J Martin Carroll within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how J Martin Carroll's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of J Martin Carroll

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.79 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 0.16 LIMIT LIMIT LIMIT LIMIT LIMIT

J Martin Carroll Ownership Network

Ownership Network List of J Martin Carroll

No Data

Ownership Network Relation of J Martin Carroll

Insider Network Chart

J Martin Carroll Owned Company Details

What does Catalent Inc do?

Who are the key executives at Catalent Inc?

J Martin Carroll is the director of Catalent Inc. Other key executives at Catalent Inc include See Remarks Scott Gunther , Group President & Biologics David Mcerlane , and SVP & CIO Charles Lickfold .

Catalent Inc (CTLT) Insider Trades Summary

Over the past 18 months, J Martin Carroll made no insider transaction in Catalent Inc (CTLT). Other recent insider transactions involving Catalent Inc (CTLT) include a net sale of 1,114 shares made by Ricky Hopson , a net sale of 846 shares made by Scott Gunther , and a net sale of 3,556 shares made by Alessandro Maselli .

In summary, during the past 3 months, insiders sold 387 shares of Catalent Inc (CTLT) in total and bought 0 shares, with a net sale of 387 shares. During the past 18 months, 14,610 shares of Catalent Inc (CTLT) were sold and 22,000 shares were bought by its insiders, resulting in a net purchase of 7,390 shares.

Catalent Inc (CTLT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Catalent Inc Insider Transactions

No Available Data

J Martin Carroll Mailing Address

Above is the net worth, insider trading, and ownership report for J Martin Carroll. You might contact J Martin Carroll via mailing address: C/o Catalent, Inc., 14 Schoolhouse Road, Somerset Nj 08873.

Discussions on J Martin Carroll

No discussions yet.